Tagged biologics-contract-development

Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
Press Release

Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development

 Read More
Tanvex CDMO to Exhibit at the 15th Annual World ADC Conference in San Diego
Press Release

Tanvex CDMO to Exhibit at the 15th Annual World ADC Conference in San Diego

 Read More
Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals
Press Release

Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals

 Combining Tanvex’s biosimilar development expertise and U.S. FDA-licensed commercial-scale facility in San Diego, California, with Bora’s extensive global CDMO capabilities, the alliance aims to provide comprehensive solutions to biologics CDMO customers around the world. Read More
Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05
Press Release

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05

 FDA Approval of Nypozi™ and FDA BLA Acceptance of TX-05 Further Validates Tanvex's Expertise in Biologics Development and Manufacturing. Read More
Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars
Press Release

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

 New biologics outsourcing solution provider leverages proven track record of Tanvex BioPharma USA Inc. to help early-stage companies bring mammalian and microbial derived biologics from concept to commercialization. Read More